Immunotherapy has emerged as a groundbreaking approach in the treatment of various diseases, particularly cancer. Its main premise is to harness the body's immune system to fight off diseases, offering a unique and often more effective alternative to traditional therapies.
Immunotherapy, also known as biologic therapy, involves the use of substances to stimulate or suppress the immune system to help the body fight cancer, infections, and other diseases. Some forms of immunotherapy are also known as targeted therapies because they target specific parts of the immune system.
Immunotherapies can be broadly categorized into active, passive, and hybrid types. Active immunotherapy stimulates the immune system to react against an antigen, while passive immunotherapies involve the administration of immune components, such as antibodies. Hybrid immunotherapies combine these approaches.
Immunotherapy is primarily used in the treatment of cancer, but its potential applications extend much further. It is being explored in the treatment of diseases such as multiple sclerosis, tuberculosis, and HIV/AIDS. The advent of personalized medicine has also opened up opportunities for targeted immunotherapies.
Despite its promise, immunotherapy is not without challenges. Issues such as immune-related adverse events, high costs, and the need for individualized treatment plans pose significant hurdles. However, continuous research and technological advancements promise to address these challenges and expand the scope of immunotherapy.
Immunotherapy represents a significant shift in our approach to treating diseases, with the potential to revolutionize healthcare. As physicians, understanding this dynamic field is essential to provide the best possible care to our patients and navigate the evolving landscape of modern medicine.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation